Weisel, K., & Goldschmidt, H. (2016). Analysis of renal impairment in MM-003: A phase III study of pomalidomide + low-dose dexamethasone versus high-dose dexamethasone in refractory or relapsed and refractory multiple myeloma. Haematologica, 101(7), . https://doi.org/10.3324/haematol.2015.137083
Chicago-Zitierstil (17. Ausg.)Weisel, Katja, und Hartmut Goldschmidt. "Analysis of Renal Impairment in MM-003: A Phase III Study of Pomalidomide + Low-dose Dexamethasone Versus High-dose Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma." Haematologica 101, no. 7 (2016). https://doi.org/10.3324/haematol.2015.137083.
MLA-Zitierstil (9. Ausg.)Weisel, Katja, und Hartmut Goldschmidt. "Analysis of Renal Impairment in MM-003: A Phase III Study of Pomalidomide + Low-dose Dexamethasone Versus High-dose Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma." Haematologica, vol. 101, no. 7, 2016, https://doi.org/10.3324/haematol.2015.137083.